Asian Vibration-Controlled Transient Elastography registry study

Registry Study of Clinical Outcomes in Patients with Steatotic Liver Disease Undergoing Liver Stiffness Measurement - AVENGERS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000062018

Enrollment

6000

Registered

2026-06-23

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonalcoholic fatty liver disease (NAFLD), which is now known as metabolic dysfunction-associated steatotic liver disease (MASLD).

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients suspected of having steatotic liver disease who underwent their first liver stiffness measurement (FibroScan) on or after January 1, 2012. 2. Age >=20 years at the time of the initial liver stiffness measurement (enrollment).

Exclusion criteria

Exclusion criteria: 1. Patients deemed unsuitable for participation in this study by the investigator. 2. Patients who declined participation in the study. 3. Patients suspected of having concomitant chronic liver diseases other than steatotic liver disease.

Design outcomes

Primary

Measure	Time frame
Whether higher liver stiffness measurement (LSM) values are associated with increased all-cause mortality.	—

Secondary

Measure	Time frame
1.Extrahepatic comorbidities 2.Liver-related events 3.Whether patient-related factors are associated with the development of extrahepatic malignancies	—

Countries

Japan

Contacts

Public ContactHideki Fujii

Osaka Metropolitan University Department of Nutrition Graduate School of Human Life and Ecology

o21717h@omu.ac.jp06-6167-1369

Outcome results